Mobilization and activation of CD4+ T cells is also crucial to mounting an effective antitumor response in DLBCL, as patients with DLBCL and >20% infiltrating CD4+ T cells have better relapse‐free survival and OS.20, 21. The gene discussed is CD4; the disease is diffuse large B-cell lymphoma.